US medical technology company Boston Scientific reports revenue in line with expectations for the third quarter. Adjusted earnings per share were also in line with expectations.
Revenue rose 1.4 percent to 5 138 million dollars (5 065). This compares with Factsets analyst consensus of 5 062.
Adjusted earnings per share came to 0.73 dollars (0.75), which is 1.4 percent above analyst consensus of 0.72.
Boston Scientific, USD millionQ3-2026ConsensusChange versus consensusQ3-2025ChangeNet sales5 1385 0621,5%5 0651,4%Adjusted earnings per share, USD0,730,721,4%0,75-2,7%Consensus data from Factset
